Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.

DR REDDYS LABORATORIES LTD (RDY)

6-K Exec appointment confidence 75% filed 2026-07-22 EX-99.1

The Board approved on July 22, 2026, the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, with induction into the Management Council.

View raw filing on EDGAR →

Keros Therapeutics, Inc. (KROS)

8-K Exec appointment confidence 75% filed 2026-07-22 Item 5.02

The filing discloses two executive transitions: Keith Regnante's resignation as CFO effective August 3, 2026, and Annita Tanini's appointment as interim principal financial officer and principal accounting officer effective August 4, 2026. While both events occur, the principal disclosed action centers on Tanini's appointment to the CFO role, including detailed compensation arrangements ($302,300 base salary, 30% bonus target, severance terms). The filing emphasizes her qualifications and new employment agreement, making the appointment the salient event, though Regnante's departure is also disclosed.

View raw filing on EDGAR →

OXO, Inc

8-K Exec appointment confidence 95% filed 2026-07-22 Item 5.02

The filing discloses the appointment of three new directors—Gemma Hemsworth, Fiona Callering, and Alistair Pemberton—to the Board of Directors of OXO, Inc., effective immediately on July 22, 2026. This is a clear executive appointment event under Item 5.02, as the principal disclosed action is persons taking board roles. Board composition changes are material to investors' assessment of governance and strategic direction.

View raw filing on EDGAR →

Serina Therapeutics, Inc. (SER)

8-K Exec appointment confidence 95% filed 2026-07-22 Item 5.02

The filing discloses the appointment of Farrell Simon, Pharm.D., to Serina's Board of Directors effective July 22, 2026, with concurrent appointment to the Audit and Compensation Committees. Dr. Simon brings significant commercial and business development expertise from his role as Chief Commercial Officer at Trevi Therapeutics and prior decade at Pfizer, making this a material governance event affecting board composition and oversight capabilities at a clinical-stage biotech company.

View raw filing on EDGAR →

Goosehead Insurance, Inc. (GSHD)

8-K Exec appointment confidence 95% filed 2026-07-22 Item 5.02

The Board of Directors approved the appointment of Mark Jones, Jr., the Company's President and Chief Operating Officer, as CEO effective January 1, 2027, to succeed retiring CEO Mark Miller.

View raw filing on EDGAR →

AMERICAN ELECTRIC POWER CO INC (AEP)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

The Board of Directors elected two new directors, David S. Marriott and Charles J. Meyers, effective July 20, 2026, and appointed them to specific board committees. This is a clear executive appointment event. While the disclosure also mentions standard non-employee director compensation, the principal action disclosed is the appointment of these two individuals to the Board, making this a material governance event affecting the composition of the company's leadership.

View raw filing on EDGAR →

MSA Safety Inc (MNESP)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

The filing discloses the election of Octavio Marquez, president and CEO of Diebold Nixdorf, to MSA Safety's Board of Directors on July 20, 2026. This is a clear appointment of a director to the company's board, which is material to investors as board composition affects governance and strategic oversight. The disclosure explicitly states "the Board of Directors of MSA Safety Incorporated elected Octavio Marquez to the Company's Board of Directors" and notes his appointment was part of the board's regular succession plans.

View raw filing on EDGAR →

FULTON FINANCIAL CORP (FULTP)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

The filing discloses the election of David S. Schulz to Fulton Financial Corporation's board of directors, effective September 14, 2026, with appointment to the Audit and Risk committees. While the disclosure includes compensatory arrangements (pro rata RSU grant of $64,400), the principal disclosed action is the appointment of a director to the board. Schulz brings significant financial leadership experience from Wesco International and Armstrong World Industries, making this a material governance event affecting board composition and expertise.

View raw filing on EDGAR →

ExlService Holdings, Inc. (EXLS)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

Bina Mehta was elected as an independent director of ExlService Holdings, effective July 16, 2026, with concurrent appointments to the Audit Committee and Compensation and Talent Management Committee.

View raw filing on EDGAR →

Apollomics Inc. (APLMW)

6-K Exec appointment confidence 92% filed 2026-07-21

The 6-K discloses the appointment of Mr. Hung-Hsien Yen to the Board of Directors effective July 20, 2026, along with his committee assignments (Audit Committee member and Nominating and Corporate Governance Committee Chairman) and compensation terms. Although two directors also resigned on the same date, the principal disclosed action is the appointment of a new director with specified governance roles and equity/cash compensation arrangements, which is the hallmark of exec_appointment under Item 5.02.

View raw filing on EDGAR →

AWARE INC /MA/ (AWRE)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

James Beecham was appointed as a Class I Director to Aware Inc's Board of Directors on July 15, 2026, upon recommendation of the Nominating and Corporate Governance Committee.

View raw filing on EDGAR →

CrossAmerica Partners LP (CAPL)

8-K Exec appointment confidence 92% filed 2026-07-21 Item 5.02

Jonathan E. Benfield was appointed Chief Financial Officer of CrossAmerica GP LLC, the general partner, effective immediately on July 20, 2026, transitioning from his interim role since March 2, 2026.

View raw filing on EDGAR →

Bleichroeder Acquisition Corp. III

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

Constantine Dakolias was appointed as a director and audit committee member of Bleichroeder Acquisition Corp. III effective July 20, 2026. The disclosure centers on the appointment of a qualified independent director with extensive investment and credit management experience, making this a clear executive appointment event material to investors evaluating the company's governance and board composition.

View raw filing on EDGAR →

Jerash Holdings (US), Inc. (JRSH)

8-K Exec appointment confidence 85% filed 2026-07-21 Item 5.02

The filing discloses the Board's nomination of Mr. Ng Tsze Lun for election as a director and his appointment as Chairman of the Board effective after stockholder approval at the 2026 annual meeting. While the filing also mentions Mr. Choi Lin Hung's decision not to stand for re-election as director and Chairman, the principal disclosed action centers on the appointment of Mr. Ng to the Chairman role. The press release reinforces this as a "Board Leadership Transition" with Mr. Ng succeeding Mr. Choi as Chairman, making the appointment the salient event.

View raw filing on EDGAR →

RoyaLand Co Ltd. (RLNDF)

6-K Exec appointment confidence 95% filed 2026-07-21

The 6-K discloses the appointment of Mr. Nazario Matachione as a member of the Board of Directors of RoyaLand Company, Ltd. effective July 16, 2026. The filing explicitly states "the Board of Directors of The RoyaLand Company, Ltd. (the "Company") appointed Mr. Nazario Matachione as a member of the Board" and provides extensive biographical detail on his qualifications and experience. This is a clear executive appointment to the board, material to investors assessing the company's governance and leadership.

View raw filing on EDGAR →

Getty Images Holdings, Inc. (GETY)

8-K Exec appointment confidence 92% filed 2026-07-21 Item 5.02

Getty Images appointed two new independent directors—Elizabeth Abrams and Thomas Walper—to its Board of Directors effective July 20, 2026. Ms. Abrams was also appointed to the Audit Committee, and both directors entered into independent director agreements providing monthly fees of $50,000 plus additional compensation.

View raw filing on EDGAR →

AMR Resources Acquisition Corp.

8-K Exec appointment confidence 92% filed 2026-07-21 Item 5.02

Three independent directors—Andrew Childs, Michael Westerman, and Karl Simich—were appointed to the board of AMR Resources Acquisition Corp. in connection with the IPO on July 16, 2026, with assignments to the Audit and Compensation Committees.

View raw filing on EDGAR →

Phio Pharmaceuticals Corp. (PHIO)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

Phio Pharmaceuticals appointed R. Todd Plott, M.D. to its Board of Directors effective July 20, 2026, increasing the board size to six members. Dr. Plott brings 30+ years of dermatologic experience and prior FDA advisory committee service, directly relevant to the company's clinical-stage development of PH-762 for skin cancers.

View raw filing on EDGAR →

Blink Charging Co. (BLNK)

8-K Exec appointment confidence 95% filed 2026-07-21

Dennis C. Schemm was elected to Blink Charging's Board of Directors effective July 19, 2026. The filing discloses his extensive financial and executive background, including current CFO role at FOX Factory and prior CFO positions at Trex Company and Continental Building Products. Board appointments of experienced executives with relevant expertise are material governance events affecting the registrant's leadership composition.

View raw filing on EDGAR →

National Energy Services Reunited Corp. (NESR)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

The Board appointed Maen Razouqi as an additional independent director, effective August 1, 2026. This is a clear executive/director appointment disclosed under Item 5.02(d). While the disclosure also mentions standard director compensation arrangements, the principal action is the appointment of a new board member, making this an exec_appointment event.

View raw filing on EDGAR →

Powerfleet, Inc. (AIOT)

8-K Exec appointment confidence 92% filed 2026-07-21

The filing discloses the election of Michael Casey as a director and his appointment as chair of the Audit Committee, effective July 15, 2026. While the filing also mentions Michael McConnell's resignation as a director, the primary focus and substantive disclosure centers on Casey's appointment to the Board and his assumption of the Audit Committee chair role. The press release emphasizes Casey's qualifications and his return to the Board, making the appointment the salient event. Director and committee chair appointments are material governance changes affecting investor assessment of board composition and oversight.

View raw filing on EDGAR →

Upland Software, Inc. (UPLD)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

Upland Software appointed Jennifer Simon as Chief Financial Officer, effective August 17, 2026. Simon brings over 20 years of finance leadership experience in software and private equity, including prior roles at NextGen Healthcare and Quest Software, and will oversee financial planning, accounting, treasury, tax, and investor relations reporting to the CEO.

View raw filing on EDGAR →

ERICSSON LM TELEPHONE CO (ERIXF)

6-K Exec appointment confidence 92% filed 2026-07-21 EX-99.1

The exhibit announces the appointment of Christophe Van de Weyer as Head of Business Area Global Communications Platform and CEO of Vonage, and his addition to Ericsson's Executive Team. While the disclosure also includes Niklas Heuveldop's departure effective August 15, 2026, the principal disclosed action is the appointment of Van de Weyer to a critical executive role. This is material as it affects leadership of a significant business unit and the composition of the Executive Team.

View raw filing on EDGAR →

GBT Technologies Inc. (GTCH)

8-K Exec appointment confidence 85% filed 2026-07-21 Item 5.02

The filing discloses the appointment of Minh Collins as both Chief Executive Officer and director of GBT Technologies, effective July 16, 2026, immediately following Patrick Bertagna's departure. While the section covers both a departure and an appointment, the principal disclosed action centers on Collins taking the CEO and board roles. The appointment of a new CEO is material to investors as it represents a change in leadership and control of the company.

View raw filing on EDGAR →

Mediaco Holding Inc. (MDIA)

8-K Exec appointment confidence 95% filed 2026-07-21 Item 5.02

The filing discloses the appointment of Brian Fisher as President of MediaCo Holding Inc., effective July 20, 2026, along with detailed compensation arrangements including a $450,000 base salary (escalating to $600,000), discretionary bonus up to 60-115% of base salary, and equity awards totaling approximately $1.94 million in restricted and performance stock units. This is a material executive appointment affecting the company's leadership structure.

View raw filing on EDGAR →

Frontier Nuclear & Minerals Inc. (FNUC)

6-K Exec appointment confidence 92% filed 2026-07-20 EX-99.1

The exhibit announces the appointment of two new directors to Frontier's Board: Joshua Girnun (Co-Founder and Managing Partner of Ridge Metals Group) and Donal Carroll (CFO of Quantum BioPharma Ltd., with 20+ years of corporate finance and public company experience). The press release explicitly states "The Board has appointed Joshua Girnun...and Donal Carroll...as new directors" and describes their qualifications and roles. While the exhibit also mentions departing directors and committee reconstitutions, the principal disclosed action is the appointment of these two new board members, making this an exec_appointment event. This is material as board composition changes affect governance and investor assessment of leadership quality.

View raw filing on EDGAR →

Lightwave Logic, Inc. (LWLG)

8-K Exec appointment confidence 95% filed 2026-07-20 Item 5.02

Lightwave Logic appointed Fred A. Graffam III as Chief Financial Officer, effective immediately on July 20, 2026. Graffam brings over 20 years of financial leadership experience and prior CFO roles at Fidium, Ascent Capital Group, and DigitalGlobe. His compensation package includes a base salary of $450,000, a performance bonus up to 40%, a sign-on cash bonus of $70,000, and restricted stock units valued at $2,400,000.

View raw filing on EDGAR →

Hanover Bancorp, Inc. /MD (HNVR)

8-K Exec appointment confidence 95% filed 2026-07-20 Item 5.02

The filing discloses the appointment of Kevin O'Connor as President of Hanover Bancorp, Inc. and Hanover Community Bank, effective July 27, 2026. While the disclosure includes compensatory details (base salary, incentive compensation eligibility, and a 10,000-share restricted stock award vesting over five years), the principal action and focus of Item 5.02(c) is the appointment itself. The compensation terms are incidental to the appointment announcement and do not constitute a standalone compensatory arrangement disclosure under Item 5.02(e).

View raw filing on EDGAR →

ROYAL CARIBBEAN CRUISES LTD (RCL)

8-K Exec appointment confidence 95% filed 2026-07-20 Item 5.02

The Board of Directors appointed Tara Bunch as a director on July 16, 2026. Ms. Bunch brings significant operational and governance experience from senior roles at Airbnb, Apple, and Hewlett-Packard, as well as board service at The Vanguard Group.

View raw filing on EDGAR →

Alpha Compute Corp (ALP)

6-K Exec appointment confidence 95% filed 2026-07-20 EX-99.1

Enzo Villani, who was Executive Chairman and Chief Investment Officer, has been appointed to serve as President of Alpha Compute Corp, effective July 16, 2026. This is a material executive appointment expanding his role to include "broader responsibility for corporate strategy, capital allocation, and operational execution." The appointment of a senior executive to a new C-suite position is material to investors assessing company leadership and governance.

View raw filing on EDGAR →

Kalaris Therapeutics, Inc. (KLRS)

8-K Exec appointment confidence 95% filed 2026-07-20 Item 5.02

The filing discloses the appointment of Liisa Bayko as Chief Financial Officer and Treasurer effective July 20, 2026, along with detailed employment terms including $475,000 base salary, up to 40% annual bonus, and a 220,000-share stock option grant. While the section also mentions Brett Hagen's resignation as Chief Accounting Officer and Amy Vandekop's interim appointment, the primary and most substantive disclosure centers on Bayko's appointment as CFO with comprehensive compensation arrangements. This is a material executive appointment affecting the company's financial leadership.

View raw filing on EDGAR →

Neuronetics, Inc. (STIM)

8-K Exec appointment confidence 80% filed 2026-07-20 Item 5.02

Nir Naor was appointed as Executive Vice President and Chief Financial Officer effective July 23, 2026, with a compensation package including $480,000 base salary and a 500,000 RSU inducement grant. The appointment reflects the company's focus on strengthening financial oversight with an executive bringing 20+ years of finance and life sciences experience.

View raw filing on EDGAR →

USA Rare Earth, Inc. (USAR)

8-K Exec appointment confidence 85% filed 2026-07-20

The filing discloses two principal executive changes: (1) Barbara Humpton's retirement as CEO effective October 1, 2026, and (2) Thrasyvoulos Moraitis's appointment as CEO on the same date, along with Michael Blitzer's appointment as Executive Chair effective immediately. While both a departure and appointment occur, the central narrative focuses on the appointment of Moraitis as the successor CEO—a highly experienced operator in rare earths with detailed compensation terms ($822,000 base salary, $5M RSU award, $1.5M inducement RSUs, $6.5M performance RSUs, and $4M make-whole award). The filing emphasizes his qualifications and role in leading the company through the Serra Verde merger integration and operational execution, making the appointment the primary disclosed event.

View raw filing on EDGAR →

COLLECTIVE ACQUISITION CORP. (IPODW)

8-K Exec appointment confidence 85% filed 2026-07-20 Item 5.02

Maximilian Staedtler was appointed as Chief Financial Officer effective July 17, 2026, bringing extensive experience in investment banking and corporate development. Elliot Richmond resigned from the CFO position but remains as Chairman and CEO.

View raw filing on EDGAR →

Aterian, Inc. (ATER)

8-K Exec appointment confidence 85% filed 2026-07-20 Item 5.02

David E. Lazar was appointed as Chief Executive Officer on July 17, 2026, following the company's change of control transaction. The appointment was accompanied by director resignations and the election of new directors (Ben-Tzi and Natan) as part of the governance restructuring.

View raw filing on EDGAR →

Kingfish Holding Corp

8-K Exec appointment confidence 85% filed 2026-07-20 Item 5.02

The filing discloses the appointment of Lisa Matthews as Chief Operating Officer and Operations Manager effective July 14, 2026. While the section also mentions Randall A. Moritz's resignation due to medical reasons on the same date, the substantive focus and forward-looking disclosure centers on the appointment of the new COO, including her background, qualifications, and board service. The appointment of a C-suite officer is material to investors assessing company leadership and operational continuity.

View raw filing on EDGAR →

APEX Tech Acquisition Inc. (TRAD-UN)

8-K Exec appointment confidence 92% filed 2026-07-20 Item 5.02

The filing discloses the appointment of Ms. Florence Ng as Chief Executive Officer effective July 20, 2026, following Mr. Shaoren Liu's resignation from that role. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CEO with detailed biographical information and a new Service Agreement. CEO appointments are material events affecting investor assessment of company leadership and governance.

View raw filing on EDGAR →

VivoPower PLC (VIVO)

6-K Exec appointment confidence 95% filed 2026-07-20

VivoPower announced the appointment of Syed Muhammad Nouman as Group Finance Director and Principal Financial Officer/Principal Accounting Officer effective July 20, 2026, ratified by the Audit Committee. This is a material executive appointment to a named officer role responsible for SEC reporting, financial control, and statutory reporting across the company's multi-jurisdictional operations.

View raw filing on EDGAR →

Polomar Health Services, Inc. (PMHS)

8-K Exec appointment confidence 95% filed 2026-07-20

The filing discloses the appointment of Douglas Beck as Chief Financial Officer and Treasurer of Polomar Health Services, Inc., effective July 15, 2026, with explicit designation as principal financial officer and principal accounting officer. This is a material executive appointment affecting the company's financial leadership and reporting structure.

View raw filing on EDGAR →

Digital Brands Group, Inc. (DBGI)

8-K Exec appointment confidence 95% filed 2026-07-20

The filing discloses the appointment of David Sosnowski as an independent director to the Board of Directors effective July 14, 2026. While the Director Agreement also specifies compensatory arrangements (annual cash retainer of $100,000 and stock option grant of 20,000 shares), the principal disclosed action is the appointment itself. The appointment of a new independent director to the board is material to investors as it affects board composition and governance.

View raw filing on EDGAR →

Solventum Corp (SOLV)

8-K Exec appointment confidence 95% filed 2026-07-20 Item 5.02

The filing discloses the appointment of Neil Zieselman as Senior Vice President, Controller and Chief Accounting Officer, effective August 10, 2026, replacing Mary Wilcox. While the disclosure includes compensatory details (base salary, bonus, equity grants, sign-on bonus), the principal action is the appointment of an officer to a key accounting and financial reporting role. The appointment of a Principal Accounting Officer for SEC reporting purposes is material to investors' assessment of the company's financial controls and governance.

View raw filing on EDGAR →

RAYONIER INC (RYN)

8-K Exec appointment confidence 95% filed 2026-07-17 Item 5.02

Rayonier announced the permanent appointment of Ryan M. Daniels as Senior Vice President, Wood Products, effective immediately, converting his interim role (held since March 2026) to a permanent position. The Board approved the appointment on July 16, 2026, with a compensation package including $450,000 base salary, 65% cash bonus eligibility, and severance plan participation.

View raw filing on EDGAR →

OPEN TEXT CORP (OTEX)

8-K Exec appointment confidence 92% filed 2026-07-17 Item 5.02

Jill Larsen was appointed to OpenText's board of directors effective immediately on July 17, 2026. Larsen is a seasoned executive with extensive HR and organizational leadership experience at major technology companies including Synopsys, Cisco, EMC, and PTC. The appointment was announced concurrently with the resignation of director Kristen Ludgate.

View raw filing on EDGAR →

QTREX Quantum Ltd. (QTEXW)

6-K Exec appointment confidence 95% filed 2026-07-17 EX-99.1

The exhibit announces the appointment of Dr. Shlomit Chappel-Ram as an independent director to QTREX's Board, effective July 14, 2026. The disclosure emphasizes her deep technical expertise in AME technology from her prior role as VP of R&D at Nano Dimension (the source of QTREX's recently acquired AME platform), making her appointment material to investors evaluating the company's ability to execute on its quantum connectivity strategy. This is a clear exec_appointment event.

View raw filing on EDGAR →

Targa Resources Corp. (TRGP)

8-K Exec appointment confidence 95% filed 2026-07-17 Item 5.02

The filing discloses the appointment of Thomas Mathiasmeier to the Board of Directors as a Class II Director on July 16, 2026, and his concurrent appointment to the Audit Committee. While the disclosure also mentions compensatory arrangements (a pro-rated restricted stock award of 477 shares), the principal disclosed action is the appointment itself. Mathiasmeier's substantial experience as President of Global Gas, Power & Emerging Markets at ConocoPhillips and his industry expertise make this a material governance event affecting the composition and expertise of the Board.

View raw filing on EDGAR →

Archimedes Tech SPAC Partners III Co. (ARCIW)

8-K Exec appointment confidence 95% filed 2026-07-17 Item 5.02

The filing discloses the appointment of Stephen N. Cannon as a Class II director of Archimedes Tech SPAC Partners III Co., effective July 13, 2026, with concurrent appointment to the audit, compensation, and nominating committees. The disclosure centers on the principal action of a person taking a board role, making this an exec_appointment event. The appointment is material as it involves a director with extensive SPAC experience joining the board of a blank-check company.

View raw filing on EDGAR →

Brand Engagement Network Inc. (BNAIW)

8-K Exec appointment confidence 95% filed 2026-07-17 Item 5.02

The filing discloses the appointment of Christian Unterseer to the Board of Directors effective July 1, 2026, in connection with the Cataneo acquisition. The principal disclosed action is a person taking a role (board director), and the disclosure includes his background as founder of the acquired company and equity compensation arrangements. This is a material executive appointment tied to a material acquisition.

View raw filing on EDGAR →

NextTrip, Inc. (NTRP)

8-K Exec appointment confidence 92% filed 2026-07-17

The filing discloses the appointment of Casey D'Ambra as President of Media, an executive officer position, effective July 13, 2026. Item 5.02(c) explicitly covers election of directors and appointment of officers. The disclosure includes her compensation structure ($205,000 base salary plus up to $50,000 bonus in restricted shares), severance terms, and background. This is a material executive appointment that would affect investor assessment of company leadership.

View raw filing on EDGAR →

Dream Finders Homes, Inc. (DFH)

8-K Exec appointment confidence 95% filed 2026-07-17 Item 5.02

Dream Finders Homes appointed Richard Beckwitt as Co-Chairman of the Board effective July 13, 2026, and Steven Fischer to the Audit Committee as an audit committee financial expert. Beckwitt, a former Co-CEO of Lennar and President of D.R. Horton, received a 400,000 RSU award as part of his appointment, reflecting significant governance changes and the addition of experienced executives to leadership positions.

View raw filing on EDGAR →